152 related articles for article (PubMed ID: 18308165)
1. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials.
Abbate A; Biondi-Zoccai GG; Appleton DL; Erne P; Schoenenberger AW; Lipinski MJ; Agostoni P; Sheiban I; Vetrovec GW
J Am Coll Cardiol; 2008 Mar; 51(9):956-64. PubMed ID: 18308165
[TBL] [Abstract][Full Text] [Related]
2. Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.
Appleton DL; Abbate A; Biondi-Zoccai GG
Catheter Cardiovasc Interv; 2008 May; 71(6):772-81. PubMed ID: 18415952
[TBL] [Abstract][Full Text] [Related]
3. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
Lamas GA; Flaker GC; Mitchell G; Smith SC; Gersh BJ; Wun CC; Moyé L; Rouleau JL; Rutherford JD; Pfeffer MA
Circulation; 1995 Sep; 92(5):1101-9. PubMed ID: 7648653
[TBL] [Abstract][Full Text] [Related]
4. Late percutaneous coronary intervention for an occluded infarct-related artery in patients with preserved infarct zone viability: a pooled analysis of cardiovascular magnetic resonance studies.
Małek LA; Silva JC; Bellenger NG; Nicolau JC; Kłopotowski M; Spiewak M; Rassi CH; Lewandowski Z; Kruk M; Rochitte CE; Rużyłło W; Witkowski A
Cardiol J; 2013; 20(5):552-9. PubMed ID: 24297771
[TBL] [Abstract][Full Text] [Related]
5. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry).
Halkin A; Stone GW; Grines CL; Cox DA; Stuckey TD; Garcia E; Guagliumi G; Mehran R; Rutherford BD; Griffin JJ; Na Y; Tcheng JE; Turco M
Am J Cardiol; 2005 Dec; 96(12):1649-55. PubMed ID: 16360352
[TBL] [Abstract][Full Text] [Related]
7. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW
JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of coronary artery aneurysm in patients with acute myocardial infarction undergoing a primary percutaneous coronary intervention.
Yip HK; Chen MC; Wu CJ; Hang CL; Hsieh KY; Fang CY; Yeh KH; Fu M
Cardiology; 2002; 98(3):132-40. PubMed ID: 12417812
[TBL] [Abstract][Full Text] [Related]
9. Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis.
Ogbu IR; Ngwudike C; Lal K; Danielian A; Daoud SN
Am Heart J Plus; 2021 Nov; 11():100063. PubMed ID: 38549742
[TBL] [Abstract][Full Text] [Related]
10. [Effects of delayed opening of infarct-related artery on late left ventricular remodeling in patients with acute anterior myocardial infarction].
Ma LK; Yu H; Huang XY; Zhu J; Feng KF; Li SG; Zhang XH; Shao ZB; Ding XM; Yan J; Gu TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):328-31. PubMed ID: 15932662
[TBL] [Abstract][Full Text] [Related]
11. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.
Lipinski MJ; Biondi-Zoccai GG; Abbate A; Khianey R; Sheiban I; Bartunek J; Vanderheyden M; Kim HS; Kang HJ; Strauer BE; Vetrovec GW
J Am Coll Cardiol; 2007 Oct; 50(18):1761-7. PubMed ID: 17964040
[TBL] [Abstract][Full Text] [Related]
12. Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.
Zhang S; Sun A; Xu D; Yao K; Huang Z; Jin H; Wang K; Zou Y; Ge J
Clin Cardiol; 2009 Aug; 32(8):458-66. PubMed ID: 19685520
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
[TBL] [Abstract][Full Text] [Related]
14. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
[TBL] [Abstract][Full Text] [Related]
15. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
Rakowski T; Dudek D; Dziewierz A; Yu J; Witzenbichler B; Guagliumi G; Kornowski R; Hartmann F; Lansky AJ; Brener SJ; Mehran R; Stone GW
EuroIntervention; 2013 Mar; 8(11):1307-14. PubMed ID: 23538158
[TBL] [Abstract][Full Text] [Related]
16. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
[TBL] [Abstract][Full Text] [Related]
17. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction.
Brodie BR; Stuckey TD; Kissling G; Hansen CJ; Weintraub RA; Kelly TA
J Am Coll Cardiol; 1996 Aug; 28(2):319-25. PubMed ID: 8800104
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
19. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
20. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
